Literature DB >> 15921219

Isolated sphenoid sinusitis after transsphenoidal hypophysectomy.

Pete S Batra1, Martin J Citardi, Donald C Lanza.   

Abstract

BACKGROUND: Literature addressing the incidence and management of sinusitis after transsphenoidal hypophysectomy is sparse.
METHODS: Retrospective chart analysis was conducted on 200 consecutive patients who had undergone transsphenoidal procedures between January 1998 and December 2001. The postoperative incidence of sinusitis was determined. Clinical characteristics, management strategy, and outcome were reviewed.
RESULTS: Fifteen of the 200 patients (7.5%) developed rhinosinusitis after transsphenoidal surgery. Seven of the patients were referred to otorhinolaryngology for further management. Three additional patients, who had undergone transsphenoidal hypophysectomy at outside institutions, also were evaluated during this time. Nine of 10 patients (90%) had isolated sphenoid sinusitis by computed tomography and/or endoscopic criteria. The most common symptoms included headaches and nasal discharge present for an average of 2.9 years. Medical management resulted in resolution of symptoms in 5 of 10 cases (50%). The remaining five patients required endoscopic sphenoidotomy for recalcitrant disease. Intraoperatively, fungal balls were identified in three cases. Mucocele formation was encountered in one case, and an infected fat graft was evident in one case. Sphenoid sinusitis was resolved successfully in all 10 cases.
CONCLUSION: A high index of suspicion must be maintained to avoid an inordinate delay in diagnosis of isolated sphenoid sinusitis in this setting, in light of the nonspecific presentation of this clinical entity. Aggressive medical and/or surgical treatment is required for resolution of refractory symptoms in this patient population.

Entities:  

Mesh:

Year:  2005        PMID: 15921219

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  7 in total

1.  Complication Rates after Endoscopic Transsphenoidal Surgery for ACTH-Secreting Pituitary Adenomas: A Comparative Analysis with GH and Nonfunctioning Adenomas.

Authors:  Juan Á Aibar-Durán; Michael Oladotun-Anka; Carlos Asencio-Cortés; Elena Valassi; Susan Webb; Juan R Gras-Cabrerizo; Joan Monserrat-Gili; Pere Tresserras Ribó; Fernando Muñoz-Hernández
Journal:  J Neurol Surg B Skull Base       Date:  2021-03-02

2.  Isolated sphenoid sinusitis or mucocele: a potential complication of endonasal transsphenoidal surgery.

Authors:  Yu-Jen Lu; Chen-Nen Chang; Ping-Ching Pai; Kuo-Chen Wei; Chi-Cheng Chuang
Journal:  J Neurooncol       Date:  2008-08-13       Impact factor: 4.130

3.  Endoscopic Endo-nasal Trans-Sphenoidal Approach for Pituitary Adenomas: A Prospective Study.

Authors:  R G Aiyer; Garima Upreti
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-08-19

4.  The posterior nasoseptal flap: A novel technique for closure after endoscopic transsphenoidal resection of pituitary adenomas.

Authors:  James Barger; Matthew Siow; Michael Kader; Katherine Phillips; Girish Fatterpekar; David Kleinberg; David Zagzag; Chandranath Sen; John G Golfinos; Richard Lebowitz; Dimitris G Placantonakis
Journal:  Surg Neurol Int       Date:  2018-02-14

5.  Analyses and treatments of postoperative nasal complications after endonasal transsphenoidal resection of pituitary neoplasms.

Authors:  You Cheng; Fei Xue; Tian-You Wang; Jun-Feng Ji; Wei Chen; Zhi-Yi Wang; Li Xu; Chun-Hua Hang; Xin-Feng Liu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  A Modified Microscopic-Endoscopic Bilateral Transseptal Approach for Pituitary Adenomas: Comparisons of Nasal Outcome and Quality of Life Using the Microscopic Transnasal Approach.

Authors:  Junjie Zhong; Yanfang Gu; Jie Zheng; Bojie Yang; Zengxin Qi; Tianwen Li; Chao Shen; Zhifeng Shi
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

7.  Effects of nasal irrigation after endoscopic transsphenoidal resection in patients with pituitary adenomas: A randomized controlled trial.

Authors:  Peng Xu; Shuling Liu; Yahong Dong; Wei Liang; Zijun Li; Fang Liu
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.